---
layout: post
title: "Blood Pressure and Pulse Donor Eligibility Requirements: Compliance Policy; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:59:15 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-11118
original_published: 2022-05-24 00:00:00 +0000
significance: 8.00
---

# Blood Pressure and Pulse Donor Eligibility Requirements: Compliance Policy; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** May 24, 2022 00:00 UTC
**Document Number:** 2022-11118

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance entitled "Blood Pressure and Pulse Donor Eligibility Requirements: Compliance Policy; Draft Guidance for Industry." The draft guidance document addresses certain regulatory requirements for determining donor eligibility that apply to blood establishments that collect blood and blood components for transfusion or for further manufacturing use, including Source Plasma. In a final rule dated May 22, 2015, FDA amended the regulations applicable to blood establishments for determining donor eligibility and testing blood and blood components. The revised requirements were implemented in order to assure the safety of the blood supply and to protect donor health.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/05/24/2022-11118/blood-pressure-and-pulse-donor-eligibility-requirements-compliance-policy-draft-guidance-for)
- API: https://www.federalregister.gov/api/v1/documents/2022-11118

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
